Clinical Scorecard: Metabolic Risk Profiles and Sleep Disorders: A Cross-Sectional Analysis of Long-Term High-Altitude Inhabitants Compared to the General Population

At a Glance

Key Highlights

• Sleep disturbance prevalence: lowlanders 14.9%, Plateau population 30.6%
• Distinct risk patterns for sleep disturbance observed across populations
• Tibetan highlanders showed unique associations with TyG-related metabolic indicators
• High-altitude migrants exhibited depressive symptoms linked to sleep disorders
• Serum potassium associated with anxiety and sleep disorders in Tibetans

Guideline-Based Recommendations

Diagnosis

• Assess sleep disturbances using validated questionnaires
• Consider metabolic indices in evaluating sleep health

Management

• Address environmental factors affecting sleep in high-altitude populations
• Monitor metabolic health as part of sleep disorder management

Monitoring & Follow-up

• Regularly evaluate sleep quality and metabolic markers in affected populations

Risks

• Increased risk of sleep disorders in high-altitude environments
• Potential for cognitive impairment and cardiovascular disease linked to sleep disturbances

Patient & Prescribing Data

Individuals residing at high altitudes and lowland residents

Focus on metabolic health and environmental adaptations in treatment plans

Clinical Best Practices

• Incorporate assessment of metabolic indices in sleep disorder evaluations
• Tailor interventions based on environmental and genetic factors

Related Resources & Content

• Clinical trial registration